Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience.
Young Shin ChungJung-Yun LeeHyun Soo KimEun Ji NamSang Wun KimYoung Tae KimPublished in: Yonsei medical journal (2018)
In this study, poorer survival outcomes were observed in patients who underwent NAC for treatment of non-HGSC versus those treated for HGSC. Different treatment strategies are urgently required to improve survival outcomes for patients with non-HGSC undergoing NAC.
Keyphrases
- high grade
- neoadjuvant chemotherapy
- end stage renal disease
- newly diagnosed
- transcription factor
- low grade
- ejection fraction
- locally advanced
- chronic kidney disease
- prognostic factors
- sentinel lymph node
- peritoneal dialysis
- type diabetes
- patient reported outcomes
- metabolic syndrome
- combination therapy
- replacement therapy
- genome wide analysis
- smoking cessation